Multiple endocrine neoplasia type 2 and the RET protooncogene: From bedside to bench to bedside
- 9 March 2006
- journal article
- review article
- Published by Elsevier BV in Molecular and Cellular Endocrinology
- Vol. 247 (1-2), 34-40
- https://doi.org/10.1016/j.mce.2005.10.028
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitorsOncogene, 2004
- Efficient Inhibition of RET/Papillary Thyroid Carcinoma Oncogenic Kinases by 4-Amino-5-(4-Chloro-Phenyl)-7-(t-Butyl)Pyrazolo[3,4-d]Pyrimidine (PP2)Journal of Clinical Endocrinology & Metabolism, 2003
- CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2Journal of Clinical Endocrinology & Metabolism, 2001
- Germline RET 634 Mutation Positive MEN 2A-related C-Cell Hyperplasias Have Genetic Features Consistent with Intraepithelial NeoplasiaJournal of Clinical Endocrinology & Metabolism, 2001
- A RET double mutation in the germline of a kindred with FMTCExperimental and Clinical Endocrinology & Diabetes, 2000
- Clonal patterns in phaeochromocytomas and MEN-2A adrenal medullary hyperplasias: histological and kinetic correlatesThe Journal of Pathology, 2000
- Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic miceOncogene, 2000
- Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteinesOncogene, 1998
- A New Hot Spot for Mutations in the ret Protooncogene Causing Familial Medullary Thyroid Carcinoma and Multiple Endocrine Neoplasia Type 2AJournal of Clinical Endocrinology & Metabolism, 1998
- Mutations in the RET proto-oncogene are associated with MEN 2A and FMTCHuman Molecular Genetics, 1993